citric acid, anhydrous has been researched along with Coronary Artery Disease in 4 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hudzik, B | 1 |
| Korzonek-Szlacheta, I | 1 |
| Danikiewicz, A | 1 |
| Szkodziński, J | 1 |
| Nowak, J | 1 |
| Lekston, A | 1 |
| Gąsior, M | 1 |
| Zubelewicz-Szkodzińska, B | 1 |
| Pittens, CA | 1 |
| Bouman, HJ | 1 |
| van Werkum, JW | 1 |
| ten Berg, JM | 1 |
| Hackeng, CM | 1 |
| GOTTFRIED, SP | 1 |
| FRIEDMAN, NH | 1 |
| AKERSON, IB | 1 |
| POPE, RH | 1 |
| DI MAURO, S | 1 |
| Bosch, T | 1 |
| Schmidt, B | 1 |
| Kleophas, W | 1 |
| Otto, V | 1 |
| Samtleben, W | 1 |
1 trial available for citric acid, anhydrous and Coronary Artery Disease
| Article | Year |
|---|---|
LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
Topics: Acrylic Resins; Anticoagulants; Antithrombin III; Arteriosclerosis; Biocompatible Materials; Blood C | 1997 |
3 other studies available for citric acid, anhydrous and Coronary Artery Disease
| Article | Year |
|---|---|
Platelet Volume Measurements-EDTA, Citrate, or Both?
Topics: Citrates; Citric Acid; Coronary Artery Disease; Edetic Acid; Humans; Inflammation; Platelet Count | 2018 |
Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests.
Topics: Adult; Citric Acid; Coronary Artery Disease; Drug Monitoring; Female; Hirudins; Humans; Male; Platel | 2009 |
The relation between blood organic acid soluble phosphate fractions, citric acid, protein fractions, and lipid fractions in atherosclerotic heart diseases and in lipemias.
Topics: Arteriosclerosis; Blood; Citric Acid; Coronary Artery Disease; Hyperlipidemias; Lipids; Phosphates | 1954 |